Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach*
暂无分享,去创建一个
Susan E. Abbatiello | S. Carr | R. Aebersold | A. Burlingame | L. Reiter | B. MacLean | R. Moritz | D. Chan | E. Deutsch | A. Paulovich | N. Rifai | O. Vitek | A. Hoofnagle | C. Borchers | B. Domon | D. Mani | Leigh Anderson | H. Rodriguez | R. Bradshaw | J. Botelho | D. Liebler | Tao Liu | S. Weintraub | E. Boja | C. Kinsinger | J. V. Van Eyk | E. Kuhn | P. Srinivas | Ruth Hüttenhain | R. Townsend | J. Blonder | Hasmik Keshishian | H. Neubert | J. Koomen | Sang-Won Lee | G. Whiteley | R. Grant | Gordon A. Whiteley | J. Oses-Prieto | B. Ackermann | M. Boyne | E. Mansfield | R. Bethem | Steve Carr | A. Wiita | Jerry S. H. Lee | J. Ritchie | J. Lee | Emily Boja | Susan E Weintraub | Alma L. Burlingame | John M. Koomen | Tao Liu | Lukas Reiter | Leigh Anderson | Julianne Botelho | Michael Boyne | Ralph A. Bradshaw | Daniel Chan | Jerry S.H. Lee | Sang-Won Lee | Nader Rifai | James Ritchie | Henry Rodriguez | R. Townsend | Jennifer Van Eyk | Arun Wiita | Daniel W. Chan
[1] Whole Grain Label Statements. Guidance for Industry and FDA Staff , 2006 .
[2] Pei Wang,et al. The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline , 2008, Proteomics. Clinical applications.
[3] Ruedi Aebersold,et al. Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies , 2013, Nature Protocols.
[4] Hendrik Neubert,et al. Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factor. , 2013, Analytical chemistry.
[5] S. Grebe,et al. LC-MS/MS in the Clinical Laboratory - Where to From Here? , 2011, The Clinical biochemist. Reviews.
[6] B. Favrat,et al. Validation of hepcidin quantification in plasma using LC-HRMS and discovery of a new hepcidin isoform. , 2013, Bioanalysis.
[7] T. Larson,et al. A liquid chromatography-mass spectrometry method for the quantification of urinary albumin using a novel 15N-isotopically labeled albumin internal standard. , 2007, Clinical chemistry.
[8] L. A. Currie,et al. LIMITS FOR QUALITATIVE DETECTION AND QUANTITATIVE DETERMINATION. APPLICATION TO RADIOCHEMISTRY. , 1968 .
[9] David Fenyö,et al. Mass spectrometric protein identification using the global proteome machine. , 2010, Methods in molecular biology.
[10] Christoph H Borchers,et al. Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma* , 2009, Molecular & Cellular Proteomics.
[11] P. Massion,et al. Methods for Peptide and Protein Quantitation by Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry* , 2011, Molecular & Cellular Proteomics.
[12] J. Vargo. Determination of sulfonic acid degradates of chloroacetanilide and chloroacetamide herbicides in groundwater by LC/MS/MS. , 1998, Analytical chemistry.
[13] Xu Shi,et al. Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution* , 2009, Molecular & Cellular Proteomics.
[14] Martin Eisenacher,et al. Guidelines for reporting quantitative mass spectrometry based experiments in proteomics. , 2013, Journal of proteomics.
[15] B. Matuszewski,et al. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. , 1998, Analytical chemistry.
[16] J A Sphon,et al. Use of mass spectrometry for confirmation of animal drug residues. , 1978, Journal - Association of Official Analytical Chemists.
[17] L L Needham,et al. Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. , 1996, Clinical chemistry.
[18] K. Barnhart,et al. Rapid verification of candidate serological biomarkers using gel-based, label-free multiple reaction monitoring. , 2011, Journal of proteome research.
[19] O. Nemirovskiy,et al. Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine. , 2007, Analytical biochemistry.
[20] Susan E Abbatiello,et al. Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry. , 2010, Clinical chemistry.
[21] Lloyd A. Currie,et al. Limits for qualitative detection and quantitative determination , 1968 .
[22] Timothy Olah,et al. Mechanistic investigation of ionization suppression in electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.
[23] Steven A. Carr,et al. Updating the MCP Proteomic Publication Guidelines , 2009 .
[24] J. Garin,et al. Isotope dilution strategies for absolute quantitative proteomics. , 2009, Journal of proteomics.
[25] Johannes Griss,et al. The Proteomics Identifications (PRIDE) database and associated tools: status in 2013 , 2012, Nucleic Acids Res..
[26] H. Parsons. Stable isotopes in the management and diagnosis of inborn errors of metabolism. , 1990, Canadian journal of physiology and pharmacology.
[27] Ruedi Aebersold,et al. The Mtb proteome library: a resource of assays to quantify the complete proteome of Mycobacterium tuberculosis. , 2013, Cell host & microbe.
[28] S. Stein,et al. Establishing the fitness for purpose of mass spectrometric methods , 2003, Journal of the American Society for Mass Spectrometry.
[29] Sam H Haidar,et al. 2012 white paper on recent issues in bioanalysis and alignment of multiple guidelines. , 2012, Bioanalysis.
[30] John Chilton,et al. Using iRT, a normalized retention time for more targeted measurement of peptides , 2012, Proteomics.
[31] L. Cohen,et al. Quantitation of endogenous analytes in biofluid without a true blank matrix. , 2003, Analytical chemistry.
[32] A. Lawson. The scope of mass spectrometry in clinical chemistry. , 1975, Clinical chemistry.
[33] Fabio Garofolo,et al. Bioanalytical Method Validation , 2004 .
[34] Brendan MacLean,et al. Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .
[35] Jeffrey R. Whiteaker,et al. Sequential Multiplexed Analyte Quantification Using Peptide Immunoaffinity Enrichment Coupled to Mass Spectrometry* , 2011, Molecular & Cellular Proteomics.
[36] Robert L. Moritz,et al. An assessment of current bioinformatic solutions for analyzing LC‐MS data acquired by selected reaction monitoring technology , 2012, Proteomics.
[37] Viswanath Devanarayan,et al. Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement , 2006, Pharmaceutical Research.
[38] Jonathan F. Russell,et al. If a job is worth doing, it is worth doing twice , 2013, Nature.
[39] Deepak R. Mani,et al. Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics , 2012, BMC Bioinformatics.
[40] Ruedi Aebersold,et al. The Need for Guidelines in Publication of Peptide and Protein Identification Data , 2004, Molecular & Cellular Proteomics.
[41] D. Dominguez,et al. Proteomics: Clinical Applications , 2007, American Society for Clinical Laboratory Science.
[42] R. Sederoff,et al. Peptide Production and Decay Rates Affect the Quantitative Accuracy of Protein Cleavage Isotope Dilution Mass Spectrometry (PC-IDMS)* , 2012, Molecular & Cellular Proteomics.
[43] Samuel I. Miller,et al. Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean. , 2009, Analytical chemistry.
[44] Philip Timmerman,et al. 'Large Meets Small': connecting the bioanalytical community around peptide and protein bioanalysis with LC-MS(/MS). , 2012, Bioanalysis.
[45] D R Mani,et al. Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma* , 2011, Molecular & Cellular Proteomics.
[46] Levon M Khachigian,et al. DNAzyme Targeting c-jun Suppresses Skin Cancer Growth , 2012, Science Translational Medicine.
[47] Richard Z. Liu,et al. A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer , 2011, Proteomics. Clinical applications.
[48] J Cummings,et al. Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs , 2010, British Journal of Cancer.
[49] Lukas N. Mueller,et al. Full Dynamic Range Proteome Analysis of S. cerevisiae by Targeted Proteomics , 2009, Cell.
[50] Jurgen Burhenne,et al. Bioanalytical method validation , 2008 .
[51] S. Carr,et al. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry , 2013, Nature Methods.
[52] S. Carr,et al. Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*S , 2007, Molecular & Cellular Proteomics.
[53] Eric W. Deutsch,et al. The PeptideAtlas project , 2005, Nucleic Acids Res..
[54] P. Timmerman,et al. Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis Forum. , 2010, Bioanalysis.
[55] Jacob D. Jaffe,et al. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia , 2013, Nature Genetics.
[56] Michael H. Ramsey,et al. Quality concepts and practices applied to sampling—an exploratory study , 1995 .
[57] T. Kuhara. Noninvasive human metabolome analysis for differential diagnosis of inborn errors of metabolism. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[58] Steven A Carr,et al. Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.
[59] Henry H. N. Lam,et al. A database of mass spectrometric assays for the yeast proteome , 2008, Nature Methods.
[60] F. Vandenesch,et al. Isotope-labeled Protein Standards , 2007, Molecular & Cellular Proteomics.
[61] A. Hoofnagle,et al. Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies. , 2013, Clinical chemistry.
[62] Kristian Linnet,et al. Partly nonparametric approach for determining the limit of detection. , 2004, Clinical chemistry.
[63] Christoph H Borchers,et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.
[64] R. Aebersold,et al. mProphet: automated data processing and statistical validation for large-scale SRM experiments , 2011, Nature Methods.
[65] Olga Vitek,et al. Statistical design of quantitative mass spectrometry-based proteomic experiments. , 2009, Journal of proteome research.
[66] Ruedi Aebersold,et al. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes , 2010, Nature Methods.
[67] Jingchun Chen,et al. ATAQS: A computational software tool for high throughput transition optimization and validation for selected reaction monitoring mass spectrometry , 2011, BMC Bioinformatics.
[68] Juncong Yang,et al. MRM‐based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma , 2012, Proteomics.
[69] Bernhard Kuster,et al. Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present , 2012, Analytical and Bioanalytical Chemistry.
[70] Daniel Figeys,et al. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers. , 2007, Advances in cancer research.
[71] Ronald J. Moore,et al. Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum , 2012, Proceedings of the National Academy of Sciences.
[72] P. Solter,et al. Quantification of NTproBNP in rat serum using immunoprecipitation and LC/MS/MS: a biomarker of drug-induced cardiac hypertrophy. , 2008, Analytical chemistry.
[73] J. Pitt,et al. Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. , 2002, Clinical chemistry.
[74] Ludovic C. Gillet,et al. Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis* , 2012, Molecular & Cellular Proteomics.
[75] Luis Mendoza,et al. PASSEL: The PeptideAtlas SRMexperiment library , 2012, Proteomics.
[76] Pei Wang,et al. A targeted proteomics–based pipeline for verification of biomarkers in plasma , 2011, Nature Biotechnology.
[77] John D. Venable,et al. Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra , 2004, Nature Methods.
[78] S. Carr,et al. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease , 2011, Nature Biotechnology.
[79] W. C. Brumley,et al. Regulatory mass spectrometry. , 1981, Biomedical mass spectrometry.
[80] Susan E Abbatiello,et al. Evaluation of Large Scale Quantitative Proteomic Assay Development Using Peptide Affinity-based Mass Spectrometry* , 2011, Molecular & Cellular Proteomics.
[81] S. Bates,et al. European Bioanalysis Forum recommendation on method establishment and bioanalysis of biomarkers in support of drug development. , 2012, Bioanalysis.
[82] Christophe Bruley,et al. PSAQ™ standards for accurate MS-based quantification of proteins: from the concept to biomedical applications. , 2012, Journal of mass spectrometry : JMS.
[83] Ralph A Bradshaw. Revised draft guidelines for proteomic data publication. , 2005, Molecular & cellular proteomics : MCP.
[84] R. Beynon,et al. Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides , 2005, Nature Methods.
[85] Brendan MacLean,et al. Label-Free Quantitation of Protein Modifications by Pseudo Selected Reaction Monitoring with Internal Reference Peptides , 2012, Journal of proteome research.
[86] Eric W. Deutsch,et al. PASSEL: The PeptideAtlas SRMexperiment library , 2012, Proteomics.
[87] K. Kito,et al. Mass Spectrometry-Based Approaches Toward Absolute Quantitative Proteomics , 2008, Current genomics.
[88] Derek J. Bailey,et al. Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics* , 2012, Molecular & Cellular Proteomics.
[89] Christoph H Borchers,et al. Design, Implementation and Multisite Evaluation of a System Suitability Protocol for the Quantitative Assessment of Instrument Performance in Liquid Chromatography-Multiple Reaction Monitoring-MS (LC-MRM-MS)* , 2013, Molecular & Cellular Proteomics.
[90] Hendrik Neubert,et al. Online high-flow peptide immunoaffinity enrichment and nanoflow LC-MS/MS: assay development for total salivary pepsin/pepsinogen. , 2010, Clinical chemistry.
[91] Jarrett D. Egertson,et al. Multiplexed MS/MS for Improved Data Independent Acquisition , 2013, Nature Methods.
[92] B. Domon,et al. Targeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer* , 2012, Molecular & Cellular Proteomics.
[93] R. Aebersold,et al. Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions , 2012, Nature Methods.
[94] David R Goodlett,et al. Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. , 2012, Journal of proteome research.
[95] S. Gygi,et al. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[96] Lisa M. Chung,et al. Review of software tools for design and analysis of large scale MRM proteomic datasets. , 2013, Methods.
[97] Eric W. Deutsch,et al. A complete mass-spectrometric map of the yeast proteome applied to quantitative trait analysis , 2013, Nature.
[98] R. Boyd,et al. Mass spectrometry in trace analysis , 1998 .
[99] K. Linnet,et al. Evaluation of regression procedures for methods comparison studies. , 1993, Clinical chemistry.
[100] Nichole L. King,et al. The PeptideAtlas Project , 2010, Proteome Bioinformatics.
[101] Ruedi Aebersold,et al. Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics , 2012, Science Translational Medicine.
[102] C. Tian,et al. Software for quantitative proteomic analysis using stable isotope labeling and data independent acquisition. , 2011, Analytical chemistry.